Case number 1:18-cv-01818
Astellas Pharma Inc. et al v. Xellia Pharmaceuticals ApS et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 30, 2019 | 14 | Patent/Trademark Report to Commissioner (1) |
| Apr 30, 2019 | 14 | Order (1) |
| Apr 30, 2019 | 14 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,104 B1. (Attachments: # (1) Order)(nms) |
| Apr 29, 2019 | 12 | Proposed Order (2) Docket Text: PROPOSED ORDER of Dismissal by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC. (Fahnestock, Derek) |
| Apr 29, 2019 | 13 | Order (1) Docket Text: ORDER Of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 4/29/2019. (nms) |
| Apr 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] STIPULATION and Proposed Order to extend time to move, plead or otherwise respond to the Complaint to April 29, 2019 (*Reset Answer Deadlines: Xellia Pharmaceuticals ApS answer due 4/29/2019; Xellia Pharmaceuticals, Inc. answer due 4/29/2019). Signed by Judge Richard G. Andrews on 4/8/2019. (nms) |
| Apr 8, 2019 | 11 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to April 29, 2019 - filed by Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc.. (Keller, Karen) |
| Mar 25, 2019 | N/A | SO ORDERED (0) |
| Mar 21, 2019 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to April 8, 2019 - filed by Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc.. (Keller, Karen) |
| Feb 21, 2019 | N/A | SO ORDERED (0) |
| Feb 20, 2019 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to move, plead or otherwise respond to the Complaint to March 25, 2019 - filed by Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc.. (Keller, Karen) Modified on 2/21/2019 (nms). |
| Jan 23, 2019 | N/A | SO ORDERED (0) |
| Jan 21, 2019 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to February 21, 2019 - filed by Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc.. (Keller, Karen) |
| Nov 23, 2018 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC: For Xellia Pharmaceuticals ApS waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Nov 23, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC: For Xellia Pharmaceuticals, Inc. waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Nov 21, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 19, 2018 | 1 | Complaint (9) |
| Nov 19, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Xellia Pharmaceuticals ApS on 11/19/2018; Xellia Pharmaceuticals, Inc. on 11/19/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Nov 19, 2018 | 1 | Exhibit A (12) |
| Nov 19, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 19, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Nov 19, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/9/2018. Date of Expiration of Patent: 1/8/2021.Thirty Month Stay Deadline: 1/8/2021. (lak) |
| Nov 19, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,104 B1. (lak) |
| Nov 19, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC. (lak) |
| Nov 19, 2018 | 1 | Main Document (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2507287.) - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(lak) |
| Nov 19, 2018 | 1 | Complaint* (1) |
